Kalshi launches perpetual futures tied to US 500 stock index
Kalshi has introduced a new perpetual futures contract that is linked to its US 500 index. This contract will allow traders to hold positions indefinitely, without the need to roll over. It aims to provide stock market exposure, a key step in Kalshi’s expansion as a financial exchange. The CEO mentioned leveraging long or short […]
Fed plans bank-supervision overhaul to strengthen accountability, says Vice Chair Michelle Bowman
The Federal Reserve is set to realign its bank supervision system for increased accountability and efficient decision-making. Five new geographic supervisory regions will be established, each led by a regional leader. This new structure aims to address concerns raised in an independent review of Silicon Valley Bank’s collapse. The Fed will also reconsider asset thresholds […]
US EIA lifts Brent forecast to $98 as Iran war tightens global supplies
The US Energy Information Administration has revised its oil price forecasts for the coming years due to supply issues. Global benchmark Brent crude is expected to average approximately $98 a barrel in 2026. Retail diesel prices are projected to remain high initially before gradually declining to around $4.50 in 2027. Improvements in Middle Eastern oil […]
US software shares hit 2026 highs as AI disruption fears ease
US software stocks are witnessing robust growth, fueled by optimistic earnings projections and partnerships in AI. Major players like Salesforce and Accenture have showcased impressive earnings, aiding the sector’s revival. Analysts suggest that fears of AI disrupting the software landscape are exaggerated. Nonetheless, challenges persist as technology evolves, potentially affecting traditional business models.
How Jefferies is reshuffling its portfolio as soaring bond yields give Nifty bulls sleepless nights
Jefferies is favouring largecaps as rising bond yields pressure Indian equities, citing relatively attractive valuations and a narrowing earnings gap with midcaps. The brokerage has added Kotak Mahindra Bank and Reliance Industries to its preferred portfolio.
Sebi says Jane Street’s appeal for more details a delaying ploy
Sebi has called Jane Street’s demand for additional documents a “dilatory” tactic as the Wall Street trading firm challenges the regulator’s market manipulation allegations. The dispute centres on Jane Street’s trading in Nifty Bank derivatives. The outcome could influence how global trading firms assess regulatory risks in India’s derivatives market, with the hearing set to […]
MFs kept buying these 10 microcaps for 2 straight quarters; stocks surge up to 70% in 3 months
Mutual funds increased holdings in 64 Nifty Microcap 250 companies for two consecutive quarters. Ten microcap stocks gained 25%-68% in three months, led by Electronics Mart India, Sky Gold, Bluestone Jewellery, Sudarshan Chemical and Timex Group, highlighting strong institutional buying and investor interest.
Current gold prices provide a better entry point as central bank demand supports the outlook, says Tata Mutual Fund
Gold prices have corrected sharply from their January peak, but Tata Mutual Fund believes the long-term outlook remains supported by central bank buying, fiscal risks and geopolitical uncertainty. The fund house also remains constructive on silver amid persistent supply deficits.
Banks vs NBFCs: Which stocks could benefit as RBI eyes rate hike for first time in 3 years?
The RBI’s expected first rate hike in three years could have a mixed impact on banks and NBFCs. While higher funding costs may pressure NBFC margins, lenders with floating-rate assets and strong liquidity could benefit. Brokerages favour HDFC Bank, ICICI Bank, Kotak Mahindra Bank, Bajaj Finance and Tata Capital.
Motilal Oswal initiates coverage on Molbio Diagnostics stock with Buy, sees 21% upside. Here’s why
Motilal Oswal initiated coverage on Molbio Diagnostics with a Buy rating and ₹1,800 target, implying 21% upside. The brokerage sees strong growth potential from decentralised molecular diagnostics, led by Molbio’s Truenat platform, which has 12,500+ devices across 90+ countries and 43 assays for 30 diseases.